Guardian Pharmacy Services beats Q3 2026 estimates and raises full-year adjusted EBITDA guidance to $136–$138M from $129–$131M
- Q3 EPS $0.33, up 32% YoY, while revenue declined 2% YoY to $371.1M
- Company issued fiscal 2026 revenue guidance in a range of $1.44B to $1.46B
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.